A new Lancet study forecast what may happen over the next 25 years if more isn't done to address antimicrobial resistant ...

As more drugs approach late-stage development for PAH, Cereno Scientific’s CEO expects more successful disease-modifying ...

Pharmaceutical companies have stereotypically ... Black Forest Labs, an image GenAI startup that only came out of stealth two months ago, has closed a a monster new round, sources say.

Two new drugs, lecanemab and donanemab, have shown the capability of slowing down the debilitating progression of Alzheimer's ...

Three years ago, the cigarette giant acquired Vectura, a British pharmaceutical firm that makes asthma inhalers, raising ...

Investors are also hedging on shares of oil and gas and defence sectors to play safe if Trump gets elected in the November 5 election ...

Liver herbal supplement Liv 52 emerged as one of India's top-selling herbal tonics in August, driven by increased cases of liver-related illnesses during the monsoon season. The Indian pharmaceutical ...

Hoping to skirt the slow pace of new drug development, researchers are leaning on AI to uncover fresh uses for known ...

Summit’s lung cancer treatment has wowed researchers. The CEO behind it is a living challenge to the assumptions of many in ...

The U.S. House of Representatives has passed the Biosecure Act to limit business with Chinese biotech companies on national ...

The union government has banned certain fixed-dose combination drugs due to concerns over safety, efficacy, and potential misuse.

Congressional Republicans are enthusiastically doubling down on the corruption openings five Republicans on the Supreme Court ...